Cx Precision Medicine
Other Pharmaceuticals and Biotechnology
Cx Precision Medicine valuation and funding history | Last updated: January 1, 2022 | 1 funding rounds
Current Valuation
N/A
As of January 1, 2022
Total Funding Raised
N/A
Across 1 round
Last Round
Accelerator/Incubator
Amount undisclosed
Last Funding
Jan 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 1, 2022 | Accelerator/Incubator | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
Cx Precision Medicine is currently valued at N/A as of January 1, 2022.
Explore More Data
Detailed analysis for Cx Precision Medicine
What is Cx Precision Medicine Worth in 2026?
Cx Precision Medicine is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Cx Precision Medicine's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Cx Precision Medicine Valuation is Determined
Private company valuations like Cx Precision Medicine's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.